Zoetis Inc’s recently made public that its Chief Executive Officer PECK KRISTIN C unloaded Company’s shares for reported $59852.0 on Feb 19 ’25. In the deal valued at $156.68 per share,382 shares were sold. As a result of this transaction, PECK KRISTIN C now holds 94,194 shares worth roughly $16.0 million.
Then, PECK KRISTIN C bought 382 shares, generating $59,852 in total proceeds.
Before that, Lagano Roxanne sold 326 shares. Zoetis Inc shares valued at $55,805 were divested by the Executive Vice President at a price of $171.18 per share. As a result of the transaction, Lagano Roxanne now holds 16,107 shares, worth roughly $2.74 million.
Leerink Partners initiated its Zoetis Inc [ZTS] rating to an Outperform in a research note published on December 02, 2024; the price target was $215. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Stifel also remained covering ZTS and reiterated its “Buy” recommendation on January 12, 2024.
Price Performance Review of ZTS
On Tuesday, Zoetis Inc [NYSE:ZTS] saw its stock fall -0.37% to $169.90. Over the last five days, the stock has gained 0.81%. Zoetis Inc shares have risen nearly 4.28% since the year began. Nevertheless, the stocks have fallen -14.33% over the past one year. While a 52-week high of $200.33 was reached on 02/06/25, a 52-week low of $144.80 was recorded on 02/18/25. SMA at 50 days reached $166.68, while 200 days put it at $177.22.
Levels Of Support And Resistance For ZTS Stock
The 24-hour chart illustrates a support level at 167.79, which if violated will result in even more drops to 165.67. On the upside, there is a resistance level at 173.41. A further resistance level may holdings at 176.91. The Relative Strength Index (RSI) on the 14-day chart is 54.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 5.02, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 23.93%. Stochastics %K at 72.68% indicates the stock is a holding.
The most recent change occurred on December 07, 2023 when Exane BNP Paribas began covering the stock and recommended ‘”an Outperform”‘ rating along with a $237 price target.
